SOPHiA GENETICS is excited to celebrate Clinical Trials Day. This blog dives a little deeper into the history of clinical trials and how they continue to advance healthcare.
Celebrating Clinical Trials Day
read more
Blogs
Diversity in Genomic Analysis: An example of how SOPHiA GENETICS has built more accurate health data analysis for diverse populations
Every person is unique. We can clearly see this within the more than one million genomic profiles from 70 different countries analyzed by our technology.
Benefits of doing genomic data analysis in house
Third party sequencing services can enable increased access to NGS testing, but if institutions do not receive access to the raw data it can limit the insights they can gain. Doing the data analysis in house can allow you to harness the power of genomic data to reveal relevant variants.
A Milestone Worth Celebrating: One Million Genomic Profiles Analyzed
SOPHiA GENETICS has reached a major milestone on a global scale by analyzing one million genomic profiles.
Evolution of precision medicine
The field of precision medicine continues to evolve but remains steadfast in its goal to provide the right treatment to the right patients at the right time. This blog examines the evolution of precision medicine and how we can achieve its promise.
How Protean BioDiagnostics utilizes SOPHiA GENETICS for more comprehensive genomic analysis and research
Larger panels may cast wider nets, but optimization with patented algorithms through our universal platform gives more actionable insights without sacrificing data quality.
Flexible alternative to traditional send out services
Increased access to genomic testing can help fulfill the promise of making precision medicine accessible to all, but the upfront investment required for institutions to start their own sequencing labs remains a barrier. This challenge can be overcome by using sequencing service.
From analysis to confident reporting at the push of a button with OncoPortal Plus
By leveraging expertly curated evidence, powered by JAX-CKB, and SOPHiA GENETICS’ patented algorithms through the SOPHiA DDM platform, users can then use OncoPortal™ Plus to accurately identify clinical associations and actionable biomarker profiles.
US Cancer Moonshot Plan to Cut Cancer Death Rate in Half
The President acknowledged that the US still has much further to come in advancing data-driven initiatives and that many Americans sadly do not realize the struggle of seeking answers during the cancer diagnostic journey until it’s too late.
Major milestones from SOPHiA GENETICS’ biggest year to date
2021 has been a big year for SOPHiA GENETICS. Here’s a recap of some of the major highlights…
Radiomics: 5 Things You Need to Know
Radiomics maximizes upon information that’s already being collected. The difference is how that info is used.
Staying a step ahead of breast cancer with data-driven medicine
About half of all breast cancer patients develop the disease outside of the period of ages 50-69 and could greatly benefit from earlier detection. Today, we know that age alone is not enough to accurately estimate breast cancer risk.